Healthcare - Biotechnology - NASDAQ - US
$ 0.9915
-1.83 %
$ 41.1 M
Market Cap
-0.63
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
45.78%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Rallybio Corporation
RLYB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart RLYB
EBIT FORECAST
EBIT Forecast Chart RLYB
NET INCOME FORECAST
Net Income Chart RLYB